Reduce Bolus Injection of Bivalirudin
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 204 participants.
Also called NCT03588611
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 204 participants
- Sponsor
- Han Yaling, MD
- Registry
-
NCT03588611
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03588611. Randomized; double masking; primary purpose treatment. Start 2019-10-01 (actual); primary completion 2021-06-26 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Reduce Bolus Injection of Bivalirudin
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Bivalirudin
- Intervention (Drug)
- Bivalirudin
- Lead sponsor
- Han Yaling, MD
Record details
- Record id
cardio:ct-nct03588611- Content hash
4ee65303389274dacb16b8fa20e6459d0567288f5347f29bda492e08ee05bf77